TR199802060T2 - Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi. - Google Patents

Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi.

Info

Publication number
TR199802060T2
TR199802060T2 TR1998/02060T TR9802060T TR199802060T2 TR 199802060 T2 TR199802060 T2 TR 199802060T2 TR 1998/02060 T TR1998/02060 T TR 1998/02060T TR 9802060 T TR9802060 T TR 9802060T TR 199802060 T2 TR199802060 T2 TR 199802060T2
Authority
TR
Turkey
Prior art keywords
aminoisoquinolins
inflammatory agents
aminopyridine derivatives
aminopyridine
derivatives
Prior art date
Application number
TR1998/02060T
Other languages
English (en)
Inventor
Hamley Peter
Macdonald James
Matz James
Tinker Alan
Original Assignee
Astra Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607717.7A external-priority patent/GB9607717D0/en
Priority claimed from GBGB9608678.0A external-priority patent/GB9608678D0/en
Priority claimed from GBGB9610892.3A external-priority patent/GB9610892D0/en
Application filed by Astra Pharmaceuticals Ltd filed Critical Astra Pharmaceuticals Ltd
Publication of TR199802060T2 publication Critical patent/TR199802060T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formül (I)'in bilesimleri, ya da onun farmasötik olarak uygun tuzlari, enantiomerleri ya da totomerlerinin özellikle iltihapli hastaliklarin tedavisi için yararli oldugu bulunmustur.
TR1998/02060T 1996-04-13 1997-04-09 Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi. TR199802060T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607717.7A GB9607717D0 (en) 1996-04-13 1996-04-13 Pharmaceutically active comounds
GBGB9608678.0A GB9608678D0 (en) 1996-04-26 1996-04-26 Pharmaceuticlly active compounds
GBGB9610892.3A GB9610892D0 (en) 1996-05-24 1996-05-24 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
TR199802060T2 true TR199802060T2 (tr) 1999-01-18

Family

ID=27268241

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02060T TR199802060T2 (tr) 1996-04-13 1997-04-09 Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi.

Country Status (21)

Country Link
US (1) US6063789A (tr)
EP (1) EP0892784A1 (tr)
JP (1) JP2000509028A (tr)
KR (1) KR20000005388A (tr)
CN (1) CN1221407A (tr)
AR (1) AR006619A1 (tr)
AU (1) AU706110B2 (tr)
BR (1) BR9708607A (tr)
CA (1) CA2251681A1 (tr)
CZ (1) CZ327698A3 (tr)
EE (1) EE9800339A (tr)
HU (1) HUP9901739A3 (tr)
ID (1) ID16575A (tr)
IL (1) IL126476A0 (tr)
IS (1) IS4862A (tr)
NO (1) NO984761L (tr)
NZ (1) NZ331932A (tr)
PL (1) PL329308A1 (tr)
SK (1) SK134698A3 (tr)
TR (1) TR199802060T2 (tr)
WO (1) WO1997038977A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69830410T2 (de) 1997-08-29 2006-01-26 Tularik Ltd. Meta-benzamidinderivate als serinprotease-inhibitoren
WO1999011622A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
EP1100789B1 (de) 1998-07-24 2005-02-09 Bayer CropScience AG Substituierte benzoylcyclohexandione
IT1302677B1 (it) 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
TW575567B (en) * 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
DE19920791A1 (de) 1999-05-06 2000-11-09 Bayer Ag Substituierte Benzoylisoxazole
DE19921424A1 (de) 1999-05-08 2000-11-09 Bayer Ag Substituierte Benzoylketone
DE19946853A1 (de) 1999-09-30 2001-04-05 Bayer Ag Substituierte Arylketone
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
ES2572263T3 (es) 2005-10-25 2016-05-31 Shionogi & Co Derivados de dihidrooxazina y tetrahidropirimidina como inhibidores de BACE 1
TW200804290A (en) * 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2147914B1 (en) 2007-04-24 2014-06-04 Shionogi&Co., Ltd. Aminodihydrothiazine derivatives substituted with cyclic groups
KR101324426B1 (ko) 2008-06-13 2013-10-31 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
EP2360155A4 (en) 2008-10-22 2012-06-20 Shionogi & Co 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
CN102834384A (zh) 2009-12-11 2012-12-19 盐野义制药株式会社 *嗪衍生物
CN101863900B (zh) * 2010-06-29 2012-07-25 天津药物研究院 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途
US9018219B2 (en) 2010-10-29 2015-04-28 Shionogi & Co., Ltd. Fused aminodihydropyrimidine derivative
WO2012057248A1 (ja) 2010-10-29 2012-05-03 塩野義製薬株式会社 ナフチリジン誘導体
EP2703399A4 (en) 2011-04-26 2014-10-15 Shionogi & Co OXAZINE DERIVATIVE AND BACE-1 HEMMER THEREOF
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663550A (en) * 1968-12-25 1972-05-16 Shionogi & Co 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
GB1379111A (en) * 1972-04-13 1975-01-02 Aspro Nicholas Ltd Preparation of fused-ring pyridine and pyrazine derivatives
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
JPH04348326A (ja) * 1990-07-09 1992-12-03 Sumitomo Electric Ind Ltd 有機非線形光学材料
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物

Also Published As

Publication number Publication date
JP2000509028A (ja) 2000-07-18
AU706110B2 (en) 1999-06-10
IS4862A (is) 1998-10-07
WO1997038977A1 (en) 1997-10-23
PL329308A1 (en) 1999-03-15
IL126476A0 (en) 1999-08-17
NO984761L (no) 1998-12-14
HUP9901739A2 (hu) 1999-09-28
NO984761D0 (no) 1998-10-12
SK134698A3 (en) 1999-06-11
AR006619A1 (es) 1999-09-08
EE9800339A (et) 1999-04-15
EP0892784A1 (en) 1999-01-27
ID16575A (id) 1997-10-16
BR9708607A (pt) 1999-08-03
AU2655097A (en) 1997-11-07
CA2251681A1 (en) 1997-10-23
CN1221407A (zh) 1999-06-30
US6063789A (en) 2000-05-16
CZ327698A3 (cs) 1999-05-12
HUP9901739A3 (en) 2000-06-28
KR20000005388A (ko) 2000-01-25
NZ331932A (en) 2000-02-28

Similar Documents

Publication Publication Date Title
TR199802060T2 (tr) Aminoisokinolinler ve aminopiridin türevlerinin iltihap önleyiciler olarak kullanimi.
SE9504661D0 (sv) New compounds
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
SE9604786D0 (sv) New compounds
ATE165830T1 (de) Dihydro pyrazolopyrrole
TR200000059T2 (tr) Piridin türevleri
TR199800436A2 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
SE9802208D0 (sv) Novel compounds
SE9803518D0 (sv) Novel compounds
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
FI951858A (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
ATE389655T1 (de) Pyrimidinderivate
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
ATE237614T1 (de) Benzo(c)chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
SE9802209D0 (sv) Novel compounds
SE9504662D0 (sv) New compounds
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
RS50033B (sr) Derivati etansulfonil-piperidina
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
TR199900013T2 (tr) Yeni bilesikler.
ATE241640T1 (de) Fusidinsäure-derivate